TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features.
Biological sciences
Cell biology
Molecular biology
Physiology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
27
03
2023
revised:
10
07
2023
accepted:
09
08
2023
medline:
6
9
2023
pubmed:
6
9
2023
entrez:
6
9
2023
Statut:
epublish
Résumé
Transmembrane 4 L six family member 5 (TM4SF5) engages in non-alcoholic steatohepatitis (NASH), although its mechanistic roles are unclear. Genetically engineered
Identifiants
pubmed: 37670786
doi: 10.1016/j.isci.2023.107625
pii: S2589-0042(23)01702-9
pmc: PMC10475478
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107625Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
J Extracell Vesicles. 2022 Sep;11(9):e12262
pubmed: 36063136
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
J Clin Invest. 2016 Dec 1;126(12):4626-4639
pubmed: 27820698
Hepatology. 2003 Dec;38(6):1449-57
pubmed: 14647056
Endocrinology. 2011 Jan;152(1):59-68
pubmed: 21047945
Cell. 2007 Apr 20;129(2):251-62
pubmed: 17448988
FEBS Lett. 2010 Apr 2;584(7):1287-95
pubmed: 20083114
J Biol Chem. 1999 May 21;274(21):15173-80
pubmed: 10329725
J Hepatol. 2021 Feb;74(2):442-457
pubmed: 33161047
Cell Mol Life Sci. 2021 Dec 18;79(1):49
pubmed: 34921636
Nat Metab. 2021 Dec;3(12):1648-1661
pubmed: 34903883
Mol Cell. 2020 Jul 2;79(1):30-42.e4
pubmed: 32473093
Clin Gastroenterol Hepatol. 2022 Dec;20(12):2809-2817.e28
pubmed: 34890795
Int Rev Cell Mol Biol. 2015;319:141-63
pubmed: 26404468
FASEB J. 2017 Apr;31(4):1461-1481
pubmed: 28073834
Molecules. 2014 Aug 25;19(9):12909-24
pubmed: 25157462
Hepatology. 2009 Apr;49(4):1316-25
pubmed: 19177595
Diabetes. 2021 Sep;70(9):2000-2013
pubmed: 34187836
Front Pharmacol. 2017 Apr 24;8:221
pubmed: 28484393
J Cell Biochem. 2006 Jun 1;98(3):632-41
pubmed: 16440309
Nutrients. 2017 Oct 20;9(10):
pubmed: 29053636
Int J Mol Sci. 2016 May 25;17(6):
pubmed: 27231906
Diabetes. 2018 Dec;67(12):2485-2493
pubmed: 30459251
Cell Rep. 2021 Nov 16;37(7):110018
pubmed: 34788612
Mol Metab. 2022 Apr;58:101451
pubmed: 35123128
J Gastroenterol. 2016 Feb;51(2):93-103
pubmed: 26346735
Chronobiol Int. 2019 Jan;36(1):57-74
pubmed: 30212233
J Clin Invest. 2008 Apr;118(4):1354-66
pubmed: 18357344
Obes Surg. 2009 Nov;19(11):1574-80
pubmed: 19756893
JHEP Rep. 2019 Nov 05;1(6):468-479
pubmed: 32039399
EMBO Rep. 2019 Sep;20(9):e47903
pubmed: 31423716
BMB Rep. 2022 Dec;55(12):609-614
pubmed: 36104259
Hepatology. 2014 Aug;60(2):565-75
pubmed: 24753132
Biochim Biophys Acta. 2011 Sep;1810(9):853-62
pubmed: 21609753
Arch Biochem Biophys. 2021 Oct 15;710:109004
pubmed: 34364885
J Pathol. 2021 Jan;253(1):55-67
pubmed: 32918742
World J Gastroenterol. 2014 Feb 21;20(7):1756-67
pubmed: 24587653
Adv Neurobiol. 2017;19:49-70
pubmed: 28933061
JCI Insight. 2018 Mar 22;3(6):
pubmed: 29563328
Cell Metab. 2019 Jun 4;29(6):1306-1319.e7
pubmed: 30956113
Front Endocrinol (Lausanne). 2022 Mar 09;13:820002
pubmed: 35355561
Neoplasia. 2022 Aug;30:100809
pubmed: 35636146